Tim Bertram
Director/Board Member chez NEXIMMUNE, INC.
Fortune : 6 M $ au 31/03/2024
Profil
Timothy A.
Bertram is the founder of ProKidney LLC, which was founded in 2019.
He holds the title of Chief Executive Officer at ProKidney LLC.
He is currently the Chief Executive Officer at Twin City Bio LLC since 2019, Chief Executive Officer at InRegen since 2016, and Independent Director at NexImmune, Inc. since 2017.
Dr. Bertram's former positions include Chief Executive Officer at RegenMed Systems, Inc., Chief Executive Officer & Director at ProKidney Corp.
from 2019 to 2023, Member at Journal Communications, Inc., Principal at Pfizer Inc. from 1999 to 2004, Principal at Procter & Gamble Co., Chief Scientific Officer at Tengion, Inc. from 2004 to 2014, Faculty Member at the University of Illinois from 1984 to 1987, and Principal at Smithkline Beecham Pharmaceuticals (India) Ltd.
from 1996 to 1999.
He obtained a doctorate degree from Iowa State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROKIDNEY CORP.
2,08% | 22/05/2023 | 3 542 669 ( 2,08% ) | 6 M $ | 31/03/2024 |
NEXIMMUNE, INC.
0,26% | 31/10/2023 | 3 127 ( 0,26% ) | 17 542 $ | 31/03/2024 |
PROKIDNEY CORP. CLASS A
-.--% | 22/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Prokidney Equity LLC
inf% | 11/07/2022 | 4 944 938 ( inf% ) | - $ | Aujourd'hui |
Postes actifs de Tim Bertram
| Sociétés | Poste | Début |
|---|---|---|
| NEXIMMUNE, INC. | Director/Board Member | 01/01/2017 |
InRegen
 InRegen Hospital/Nursing ManagementHealth Services InRegen develops cellular therapies for treating chronic kidney diseases. The firm's technology is able to identify the patient’s own healthy progenitor cells, and formulate them into a personalized product that can be re-injected into the damaged kidney for repair and regeneration. The company is headquartered in George Town, Cayman Islands. | Chief Executive Officer | 01/01/2016 |
ProKidney LLC
 ProKidney LLC Packaged SoftwareTechnology Services ProKidney LLC develops therapies for kidney disease. The company was founded by Pablo Legorreta and is headquartered in Winston-Salem, NC. | Chief Executive Officer | 01/01/2019 |
| Twin City Bio LLC | Chief Executive Officer | 01/01/2019 |
Anciens postes connus de Tim Bertram
| Sociétés | Poste | Fin |
|---|---|---|
| PROKIDNEY CORP. | Chief Executive Officer | 15/11/2023 |
| TENGION, INC. | Chief Tech/Sci/R&D Officer | 31/12/2014 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
| University of Illinois | Corporate Officer/Principal | - |
Formation de Tim Bertram
| Iowa State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| TENGION, INC. | Health Technology |
| NEXIMMUNE, INC. | Health Technology |
| PROKIDNEY CORP. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Journal Communications, Inc.
 Journal Communications, Inc. Publishing: NewspapersConsumer Services Journal Communications, Inc. is a media company with operations in television and radio broadcasting, publishing and digital media. The company operates through three segments: Publishing, Broadcasting and Corporate. The Broadcasting segment consists of 35 radio stations and 15 television stations in 12 states. The Publishing segment consists of a daily newspaper, the Milwaukee Journal Sentinel, which serves as the only major daily newspaper for the Milwaukee metropolitan area, and several community newspapers and shoppers in Wisconsin. The Corporate segment consists of unallocated corporate expenses and revenue eliminations. Journal Communications was founded in 1882 and is headquartered in Milwaukee, WI. | Consumer Services |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
| RegenMed Systems, Inc. | |
InRegen
InRegen Hospital/Nursing ManagementHealth Services InRegen develops cellular therapies for treating chronic kidney diseases. The firm's technology is able to identify the patient’s own healthy progenitor cells, and formulate them into a personalized product that can be re-injected into the damaged kidney for repair and regeneration. The company is headquartered in George Town, Cayman Islands. | Health Services |
ProKidney LLC
ProKidney LLC Packaged SoftwareTechnology Services ProKidney LLC develops therapies for kidney disease. The company was founded by Pablo Legorreta and is headquartered in Winston-Salem, NC. | Technology Services |
| Twin City Bio LLC |
